Northern Trust
ENFN

Northern Trust’s Enfusion, Inc. ENFN Stock Holding History

Northern Trust’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-435,175
Closed -$4.85M – 4524
2025
Q1 		$4.85M Sell
435,175
-7,975
-2% -$88.2K ﹤0.01% 2418
2024
Q4 		$4.56M Buy
443,150
+39,211
+10% +$379K ﹤0.01% 2555
2024
Q3 		$3.83M Buy
403,939
+60,039
+17% +$518K ﹤0.01% 2635
2024
Q2 		$2.93M Sell
343,900
-9,030
-3% -$82.6K ﹤0.01% 2694
2024
Q1 		$3.26M Buy
352,930
+2,731
+0.8% +$24K ﹤0.01% 2722
2023
Q4 		$3.4M Buy
350,199
+17,643
+5% +$165K ﹤0.01% 2706
2023
Q3 		$2.98M Buy
332,556
+109,397
+49% +$1.04M ﹤0.01% 2724
2023
Q2 		$2.5M Buy
223,159
+4,156
+2% +$36.8K ﹤0.01% 2880
2023
Q1 		$2.3M Buy
219,003
+6,513
+3% +$71.8K ﹤0.01% 2877
2022
Q4 		$2.05M Buy
212,490
+5,327
+3% +$60K ﹤0.01% 2980
2022
Q3 		$2.56M Sell
207,163
-4,594
-2% -$56K ﹤0.01% 2883
2022
Q2 		$2.16M Buy
211,757
+29,645
+16% +$328K ﹤0.01% 3017
2022
Q1 		$2.32M Sell
182,112
-7,410
-4% -$113K ﹤0.01% 3025
2021
Q4 		$3.97M Buy
+189,522
New +$3.83M ﹤0.01% 2829

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northern Trust's ENFN Position: Q2 2025 in Review

Northern Trust sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 435,175 shares — an estimated $4.85M sold.

Northern Trust first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $4.85M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Northern Trust reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 435,175 Enfusion, Inc. shares in Q2 2025, an estimated $4.85M.
  • Northern Trust first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Northern Trust's Enfusion, Inc. position peaked at $4.85M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.